ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

4483.T (4483.T) Foreign Research Coverage

A focused collection of foreign research coverage for 4483.T, organized by institution and publication date for faster discovery.

Evidence documents3
Filings0
Meetings0
Research3
Displayed research share100%
Latest evidence2026-08-05

Foreign research

JMDC: F3/27 1Q決算：市場想定と異なる好調なスタートダッシュ2026-08-05 · Morgan Stanley

M Update 2026 年 8 月 5 日 10:37 AM GMT Morgan Stanley MUFG Securities Co., Ltd.+ JMDC (4483) | Japan 林 良太郎 株式アナリスト F3/27 1Q決算：市場想定と異 なる好調なスタートダッシュ 徳永 恵理奈 アソシエイト AlphaSignals 決算リアクション 強まる 大幅超過 小幅な上振れ 弊社シナリオへの影響 実績VSコンセンサス 向こう１２か月のコンセンサ スEPSの方向性 …

JMDC: F3/27 1Q Results: Solid Start, Contrary to Market Expectations2026-08-05 · Morgan Stanley

M Update August 5, 2026 10:33 AM GMT Morgan Stanley MUFG Securities Co., Ltd.+ JMDC (4483) | Japan Ryotaro Hayashi Equity Analyst F3/27 1Q Results: Solid Start, Contrary to Market Expectations Erina Tokunaga Research Associate AlphaSignals Earnings Reaction …

JMDC (4483) 1Q results: Recovery in business for pharmaceutical medical departments; business for pharmaceutical sales and marketing departments remains strong2026-08-05 · JPMorgan

J P M O R G A N Asia Pacific Equity Research 06 August 2026 JMDC (4483) 1Q results: Recovery in business for pharmaceutical medical departments; business for pharmaceutical sales and marketing departments remains strong Overweight 4483.T, 4483 JP …

Questions this evidence can help answer

  • What changed in the latest research coverage of 4483.T?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI